American Healthcare REIT (NYSE:AHR) Given New $27.00 Price Target at KeyCorp

American Healthcare REIT (NYSE:AHR) had its price target lifted by KeyCorp from $16.00 to $27.00 in a report published on Monday, Benzinga reports. KeyCorp currently has an overweight rating on the stock.

AHR has been the subject of a number of other research reports. Morgan Stanley lifted their price objective on shares of American Healthcare REIT from $17.00 to $22.00 and gave the company an overweight rating in a report on Thursday, August 22nd. JMP Securities increased their target price on American Healthcare REIT from $16.00 to $18.00 and gave the company a market outperform rating in a research report on Wednesday, August 7th. Truist Financial boosted their price target on shares of American Healthcare REIT from $17.00 to $22.00 and gave the stock a buy rating in a report on Tuesday, September 3rd. Finally, Bank of America increased their price objective on shares of American Healthcare REIT from $19.00 to $27.00 and gave the company a buy rating in a report on Tuesday, August 20th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, American Healthcare REIT currently has an average rating of Moderate Buy and an average target price of $20.38.

American Healthcare REIT Trading Up 3.6 %

Shares of AHR stock opened at $25.41 on Monday. American Healthcare REIT has a 52-week low of $12.63 and a 52-week high of $25.92. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. The business has a 50-day simple moving average of $19.24 and a 200-day simple moving average of $15.97.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings data on Monday, August 5th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.29 by ($0.28). The company had revenue of $504.60 million during the quarter, compared to analysts’ expectations of $506.55 million. American Healthcare REIT had a negative return on equity of 2.20% and a negative net margin of 1.99%. The business’s revenue was up 7.9% on a year-over-year basis. Research analysts predict that American Healthcare REIT will post 1.28 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Stockholders of record on Friday, September 20th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.00 annualized dividend and a dividend yield of 3.94%.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors and hedge funds have recently modified their holdings of the company. Kiely Wealth Advisory Group Inc. acquired a new position in shares of American Healthcare REIT in the second quarter worth $30,000. Amalgamated Bank purchased a new position in shares of American Healthcare REIT in the 2nd quarter valued at about $33,000. Semmax Financial Advisors Inc. acquired a new position in shares of American Healthcare REIT during the second quarter worth about $45,000. CWM LLC purchased a new stake in shares of American Healthcare REIT during the second quarter worth approximately $58,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in American Healthcare REIT in the second quarter valued at approximately $110,000. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.